Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126012651 | 12601265 | 1 | I | 20160410 | 20160728 | 20160728 | PER | PL-LUPIN PHARMACEUTICALS INC.-2016-01586 | LUPIN | BADURA-STRONKA M, WINCZEWSKA-WIKTOR A, MONIES-NOWICKA A, NOWICKI M, STEINBORN B, LATOS-BIELENSKA A, MONIES D. A DE NOVO CTNNB1 NONSENSE MUTATION ASSOCIATED WITH SYNDROMIC ATYPICAL HYPEREKPLEXIA, MICROCEPHALY AND INTELLECTUAL DISABILITY: A CASE REPORT. BMC NEUROLOGY. 2016;35(35):. | 11.00 | YR | M | Y | 46.00000 | KG | 20160727 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126012651 | 12601265 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | UNKNOWN | 78154 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126012651 | 12601265 | 1 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126012651 | 12601265 | Abnormal behaviour | |
| 126012651 | 12601265 | Aggression | |
| 126012651 | 12601265 | Crying |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |